Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

How operational research influenced the scale up of antiretroviral therapy in Malawi.

Harries AD, Makombe SD, Schouten EJ, Jahn A, Libamba E, Kamoto K, Chimbwandira F.

Health Care Manag Sci. 2012 Sep;15(3):197-205. doi: 10.1007/s10729-011-9187-2. Epub 2011 Nov 24.

PMID:
22113539
2.

Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV.

Harries AD, Zachariah R, Chimzizi R, Salaniponi F, Gausi F, Kanyerere H, Schouten EJ, Jahn A, Makombe SD, Chimbwandira FM, Mpunga J.

BMC Public Health. 2011 Jul 27;11:593. doi: 10.1186/1471-2458-11-593.

3.

Malawi's contribution to "3 by 5": achievements and challenges.

Libamba E, Makombe SD, Harries AD, Schouten EJ, Yu JK, Pasulani O, Mhango E, Aberle-Grasse J, Hochgesang M, Limbambala E, Lungu D.

Bull World Health Organ. 2007 Feb;85(2):156-60.

4.

Can the initial success of the Malawi ART scale-up programme be sustained? The example of Queen Elizabeth Central Hospital, Blantyre.

van Oosterhout JJ, Kumwenda JK, Hartung T, Mhango B, Zijlstra EE.

AIDS Care. 2007 Nov;19(10):1241-6. Epub 2007 Oct 2.

PMID:
17886172
5.

A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.

Makombe SD, Jahn A, Tweya H, Thambo L, Yu JK, Hedt B, Weigel R, Nkhata A, Schouten EJ, Kamoto K, Harries AD.

World Hosp Health Serv. 2008;44(1):26-9.

PMID:
18549031
6.

A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.

Makombe SD, Jahn A, Tweya H, Thambo L, Yu JK, Hedt B, Weigel R, Nkhata A, Schouten EJ, Kamoto K, Harries AD.

J Infect Dev Ctries. 2007 Dec 1;1(3):303-7.

7.

Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.

Lowrance D, Filler S, Makombe S, Harries A, Aberle-Grasse J, Hochgesang M, Libamba E.

Trop Med Int Health. 2007 Mar;12(3):377-81.

8.

Early warning indicators for HIV drug resistance in Malawi.

Hedt BL, Wadonda-Kabondo N, Makombe S, Harries AD, Schouten EJ, Limbambala E, Hochgesang M, Aberle-Grosse J, Kamoto K.

Antivir Ther. 2008;13 Suppl 2:69-75.

PMID:
18575193
9.

Why did the scale-up of HIV treatment work? A case example from Malawi.

Harries AD, Makombe SD, Libamba E, Schouten EJ.

J Acquir Immune Defic Syndr. 2011 Aug;57 Suppl 2:S64-7. doi: 10.1097/QAI.0b013e31821f6bab.

PMID:
21857298
10.

Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi.

Harries AD, Schouten EJ, Makombe SD, Libamba E, Neufville HN, Some E, Kadewere G, Lungu D.

Bull World Health Organ. 2007 Feb;85(2):152-5.

11.

A national survey of teachers on antiretroviral therapy in Malawi: access, retention in therapy and survival.

Makombe SD, Jahn A, Tweya H, Chuka S, Yu JK, Hochgesang M, Aberle-Grasse J, Thambo L, Schouten EJ, Kamoto K, Harries AD.

PLoS One. 2007 Jul 18;2(7):e620.

12.

Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes--the case of Malawi.

Libamba E, Makombe S, Harries AD, Chimzizi R, Salaniponi FM, Schouten EJ, Mpazanje R.

Int J Tuberc Lung Dis. 2005 Oct;9(10):1062-71.

PMID:
16229216
14.

Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi.

Libamba E, Makombe S, Mhango E, de Ascurra Teck O, Limbambala E, Schouten EJ, Harries AD.

Bull World Health Organ. 2006 Apr;84(4):320-6. Epub 2006 Apr 13.

15.

Using concept mapping to explore why patients become lost to follow up from an antiretroviral therapy program in the Zomba District of Malawi.

Rachlis B, Ahmad F, van Lettow M, Muula AS, Semba M, Cole DC.

BMC Health Serv Res. 2013 Jun 11;13:210. doi: 10.1186/1472-6963-13-210.

16.

Outcomes of tuberculosis patients who start antiretroviral therapy under routine programme conditions in Malawi.

Makombe SD, Harries AD, Yu JK, Hochgesang M, Mhango E, Weigel R, Pasulani O, Fitzgerald M, Schouten EJ, Libamba E.

Int J Tuberc Lung Dis. 2007 Apr;11(4):412-6.

PMID:
17394687
17.

Assessing the quality of data aggregated by antiretroviral treatment clinics in Malawi.

Makombe SD, Hochgesang M, Jahn A, Tweya H, Hedt B, Chuka S, Yu JK, Aberle-Grasse J, Pasulani O, Bailey C, Kamoto K, Schouten EJ, Harries AD.

Bull World Health Organ. 2008 Apr;86(4):310-4.

18.

Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi.

Makombe SD, Harries AD, Yu JK, Hochgesang M, Mhango E, Weigel R, Pasulani O, Fitzgerald M, Schouten EJ, Libamba E.

Trop Doct. 2008 Jan;38(1):5-7. doi: 10.1258/td.2007.060023.

PMID:
18302849
19.

[The introduction of antiretroviral therapy in Malawi].

Zijlstra EE, van Oosterhout JJ.

Ned Tijdschr Geneeskd. 2006 Dec 16;150(50):2774-8. Dutch.

PMID:
17225792
20.

True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi.

Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ, Harries AD.

Bull World Health Organ. 2007 Jul;85(7):550-4.

Supplemental Content

Support Center